DIREXION SHS ETF TR's ticker is CURE and the CUSIP is 25459Y876. A total of 16 filers reported holding DIREXION SHS ETF TR in Q4 2017. The put-call ratio across all filers is 0.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $2,522,000 | +46.7% | 58,600 | +58.8% | 0.04% | +76.0% |
Q4 2017 | $1,719,000 | -66.3% | 36,900 | -67.1% | 0.02% | -56.9% |
Q3 2017 | $5,108,000 | +28.8% | 112,300 | +18.1% | 0.06% | -3.3% |
Q2 2017 | $3,966,000 | +375.5% | 95,100 | +293.0% | 0.06% | +361.5% |
Q1 2017 | $834,000 | – | 24,200 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtu Financial LLC | 19,954 | $2,603,000 | 0.19% |
Traynor Capital Management, Inc. | 7,735 | $1,009,000 | 0.13% |
Covestor Ltd | 827 | $108,000 | 0.07% |
Kelly Financial Services LLC | 387 | $50,474 | 0.02% |
Capital Investment Advisors, LLC | 2,945 | $384,000 | 0.01% |
Cutler Group LLC / CA | 1,740 | $227,000 | 0.01% |
Ellis Investment Partners, LLC | 201 | $26,000 | 0.01% |
HRT FINANCIAL LP | 3,509 | $457,000 | 0.00% |
Professional Financial Advisors, LLC | 30 | $4,000 | 0.00% |
Bartlett & Co. LLC | 245 | $32,000 | 0.00% |